Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Acelrx Pharmaceutica (NQ: ACRX)
2.860 USD  -0.010 (-0.35%)
Streaming Delayed Price  /  Updated: 10:26 AM EST, Dec 14, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 283,544
Open 2.830
Bid (Size) 2.840 (6)
Ask (Size) 2.860 (24)
Prev. Close 2.870
Today's Range 2.760 - 2.886
52wk Range 1.650 - 5.050
Shares Outstanding 51,320,598
Dividend Yield N/A
Performance
YTD
+39.51%
+39.51%
1 Month
-9.49%
-9.49%
3 Month
-15.88%
-15.88%
6 Month
-30.67%
-30.67%
1 Year
+43.00%
+43.00%
Top News
More News
AcelRx Pharmaceuticals to Host Analyst and Investor Day on December 11
Update on DSUVIA U.S. commercialization strategy and insights from key healthcare professionals Read More
from PR Newswire
AcelRx Pharmaceuticals to Present at the 17th Annual ASRA Pain Medicine Meeting
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings,... Read More
from PR Newswire
More News
Read More
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
from PR Newswire
Report: Exploring Fundamental Drivers Behind AcelRx Pharmaceuticals, Fossil Group, FMC, Ultragenyx Pharmaceutical, Shenandoah Telecommunications, and Marcus & Millichap — New Horizons, Emerging Trends
from GlobeNewswire News Releases
AcelRx Pharmaceuticals Announces Proposed Public Offering of Common Stock
from PR Newswire
AcelRx Pharmaceuticals to Present at Credit Suisse 27th Annual Healthcare Conference
from PR Newswire
3 Stocks to Hold for the Next 20 Years
category SWK , Market News , WELL , and 1 more.
from Motley Fool
CORRECTED-FOCUS-U.S. regulators snip red tape for medical devices to curb opioid crisis
category companyNews
from Reuters: Company News
Here's Why AcelRx Pharmaceuticals Lost as Much as 18.4% Today
category Market News , ACRX
from Motley Fool
RPT-FOCUS-U.S. regulators snip red tape for medical devices to curb opioid crisis
category companyNews
from Reuters: Company News
FOCUS-U.S. regulators snip red tape for medical devices to curb opioid crisis
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.